Page 15 - Akero Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Akero therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Akero Therapeutics Today - Breaking & Trending Today

Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00

Canaccord Genuity Group Trims Akero Therapeutics (NASDAQ:AKRO) Target Price to $56.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New Zealand General , New Zealand , United States , Catriona Yale , Jonathan Young , Akero Therapeutics Inc , Redmile Group , Securities Exchange Commission , Lord Abbett , Akero Therapeutics Company Profile , Canaccord Genuity Group , Vanguard Group Inc , Wellington Management Group , Akero Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Management Group , Akero Therapeutics Daily ,

Akero Therapeutics' (AKRO) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of Akero Therapeutics (NASDAQ:AKRO – Free Report) in a research note released on Monday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. HC Wainwright also issued estimates for Akero Therapeutics’ Q2 2024 earnings at ($0.82) EPS, Q3 2024 earnings at ($0.87) EPS, […] ....

New York , United States , Zurcher Kantonalbank Zurich Cantonalbank , Catriona Yale , Andrew Cheng , Akero Therapeutics Inc , Securities Exchange Commission , Akero Therapeutics Company Profile , Mirae Asset Global Investments Co , Td Asset Management Inc , York State Common Retirement Fund , York Mellon Corp , Akero Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Asset Global Investments , Management Inc , New York State Common Retirement Fund , Akero Therapeutics Daily ,

Robbins LLP Reminds Investors of AKRO of the Pending Lead

Robbins LLP is Investigating Allegations that Akero Therapeutics, Inc. (AKRO) Misled Investors Regarding the Viability and Efficacy of its Trial Drug. ....

Aaron Dumas Jr , Akero Therapeutics Inc , Akero Therapeutics , Aaron Dumas , Investigating Allegations , Misled Investors Regarding , Trial Drug ,

Robbins LLP Reminds Investors of AKRO of the Pending Lead Plaintiff Deadline in the Akero ...

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) ....

Aaron Dumas Jr , Akero Therapeutics Inc , Akero Therapeutics , Aaron Dumas , Investigating Allegations , Misled Investors Regarding , Trial Drug , Stock Watch ,

Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO

Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New York , United States , France General , City Of , United Kingdom , Tel Aviv , Los Angeles , Danielle Peyton , Abrahaml Pomerantz , Prnewswire Pomerantz , Akero Therapeutics Inc , Akero Therapeutics , Lead Plaintiff ,